LL-37
Also known as Cathelicidin, hCAP-18/LL-37
LL-37 is one of the body's own germ-fighting peptides, studied for killing microbes, healing wounds, and tuning the immune system.
One-dose burn-down
Half-life
1.0 h
Tmax
18 min
Typical dose
100 mcg
Human cathelicidin antimicrobial peptide studied for antimicrobial, wound-healing and immunomodulatory effects.
Mechanism of action
Cationic amphipathic peptide that disrupts microbial membranes and modulates innate immunity (chemotaxis, angiogenesis, wound healing).
Research peptide — no approved systemic use. No human pharmacokinetic data exists; half-life is an animal/in-vitro estimate. Only controlled human data is topical.
Track LL-37 for free
Log your doses and PeptideBuddy models LL-37's half-life into a live chart so you always know how much is active — plus reminders, reconstitution and protocol planning.
Start tracking free